表紙:医療向け相互運用性ソリューションの世界市場
市場調査レポート
商品コード
993401

医療向け相互運用性ソリューションの世界市場

Healthcare Interoperability Solutions

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 398 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.11円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

医療向け相互運用性ソリューションの世界市場
出版日: 2022年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 398 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の医療向け相互運用性ソリューションの市場規模は、分析期間(2020年~2027年)に11.3%のCAGRで成長する見通しで、2020年の25億米ドルから、2027年には53億米ドルに達すると予測されています。

当レポートで分析されているセグメントの1つであるサービスは、分析期間中に11.8%のCAGRで成長し、31億米ドルに達すると予測されています。

当レポートは、世界の医療向け相互運用性ソリューション市場について調査しており、Covid-19の影響、動向や成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

  • Allscripts Healthcare Solutions, Inc.
  • Cerner Corporation
  • EPIC Systems Corporation
  • Infor, Inc.
  • Interfaceware, Inc.
  • Intersystems Corporation
  • Jitterbit
  • Koninklijke Philips NV
  • Nextgen Healthcare, Inc.
  • Orion Health Group Limited
  • OSP Labs
  • Quality Systems
  • Visolve, Inc.

目次

I. 調査手法

II. エグゼクティブサマリー

  • 市場概要
    • インフルエンサー市場の洞察
    • 世界市場の軌跡
    • Covid-19の影響と迫り来る世界の景気後退
  • 主要企業
  • 動向と推進要因
  • 世界市場の見通し

III. 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

IV. 競合

  • 企業プロファイル:35社
目次
Product Code: MCP21929

Global Healthcare Interoperability Solutions Market to Reach US$4.4 Billion by the Year 2026

Interoperability in the healthcare sector has risen considerably in the past few years. The market expansion is triggered by implementation of healthcare IT interoperability regulations in various countries. Government agencies in countries like the US have made it mandatory for healthcare organizations to comply with interoperability guidelines. Factors such as policy requirements and governmental regulations are creating strong demand for data integration and analytics systems. These factors are pushing the uptake of healthcare IT applications and slated to benefit providers of healthcare interoperability systems. Ongoing shift towards value-base patient care along with emergence of innovative healthcare delivery models is expected to boost adoption of healthcare interoperability systems. The demand for these solutions is also propelled by the need to ensure connectivity of medical devices and systems through the care continuum. The market is likely to receive a major impetus from increasing uptake of app integration, application programming interface integration, data integration, data cleansing, data interoperability and data analytics solutions. The HER Incentive Programs have been renamed Promoting Interoperability and the 21st Century Cures Act. Seamless and safe exchange of information across the healthcare ecosystem will facilitate digital health achieving its optimal potential.

Amid the COVID-19 crisis, the global market for Healthcare Interoperability Solutions estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$4.4 Billion by 2026, growing at a CAGR of 12.4% over the analysis period. Services, one of the segments analyzed in the report, is projected to grow at a 13.4% CAGR to reach US$2.8 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software segment is readjusted to a revised 11% CAGR for the next 7-year period. This segment currently accounts for a 45.1% share of the global Healthcare Interoperability Solutions market. The global market is led by the services segment owing to increasing transition of healthcare facilities towards cloud-based platforms and cloud computing. The move enables users to reduce operating costs and improve performance of various processes and applications. Growth in the software segment is due to increasing requirement for seamless access to patient data coupled with adoption of healthcare IT solutions for quality care delivery and enhanced patient satisfaction.

The U.S. Market is Estimated at $1.2 Billion in 2021, While China is Forecast to Reach $187.7 Million by 2026

The Healthcare Interoperability Solutions market in the U.S. is estimated at US$1.2 Billion in the year 2021. The country currently accounts for a 51.94% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$187.7 Million in the year 2026 trailing a CAGR of 18.6% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.7% and 11.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11% CAGR while Rest of European market (as defined in the study) will reach US$203.9 Million by the end of the analysis period. North America retains the imposing position in the healthcare interoperability solutions market and accounts for the majority stake due to increasing demand for quality and efficient healthcare delivery along with the pressing requirement to curb healthcare expenditure. The market growth is fueled by rising implementation of HER across healthcare organizations. Future expansion of the regional market is poised to be favored by favorable regulations and initiatives to improve efficiency of the healthcare system. The market in Asia-Pacific region is buoyed by high burden on the healthcare system that requires advanced interoperability solutions to increase the efficiency and productivity.

Select Competitors (Total 68 Featured) -

  • Allscripts Healthcare Solutions, Inc.
  • Cerner Corporation
  • EPIC Systems Corporation
  • Infor, Inc.
  • Interfaceware, Inc.
  • Intersystems Corporation
  • Jitterbit
  • Koninklijke Philips NV
  • Nextgen Healthcare, Inc.
  • Orion Health Group Limited
  • OSP Labs
  • Quality Systems
  • Visolve, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • A Prelude to Healthcare Interoperability Solutions
    • Merits of Healthcare Interoperability
    • Barriers to Healthcare Interoperability
    • Impact of Covid-19 and a Looming Global Recession
    • 2020: A Year of Disruption & Transformation
    • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed
    • EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • COVID-19 Pandemic Provides Impetus to Healthcare Interoperability Solutions
    • Importance of Healthcare Interoperability Picks up Momentum in the Covid-19 Era
    • Global Market Overview and Prospects
    • Global Healthcare Interoperability Solutions Market to Glimmer with Robust Health
    • Drivers Pushing Healthcare Interoperability Market Forward into Bright Future
    • Services Segment Claims Dominating Share
    • Diagnosis Dominates Applications Category
    • Hospitals Remain Primary End-Use Segment
    • North America Sways Healthcare Interoperability Solutions Market with Majority Stake
    • Competitive Scenario
    • New Product Launch & Portfolio Expansion: Strategies to Stay Competitive in Healthcare Interoperability Solutions Market
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Salient Factors with Pivotal Role Cause Shift towards Healthcare Interoperability
    • Focus on Patient-Centered Care Delivery Highlights the Growing Need for Interoperability
    • Sharp Rise in Clinical Data Volume and Streamlining Imaging Workflow Present Lucrative Growth Opportunities
    • Growing Patient Volume, Data Privacy Concerns and Need for Accuracy in Data Management Drive Market Demand
    • Increasing Complexity of Healthcare Operations to Spur Demand for Healthcare Interoperability Solutions
    • EXHIBIT 2: Global Healthcare IT Market (2020): Percentage Breakdown of Spending by Sector
    • Large Installation Base of EHR Systems Drives the Need for EHR Interoperability
    • Factors Triggering Adoption of EHR
    • Rise in Integration of Disruptive Technologies in EHR
    • EHR Interoperability and Associated Issues
    • Digitalization of Healthcare and Technological Advancements
    • Digital Health Investments Record Strong Growth
    • EXHIBIT 3: Digital Health Funding (in US$ billion): 2015-2020
    • Healthcare System's Expedited Shift towards Telemedicine Spurs Opportunity for Healthcare Interoperability Solutions
    • EXHIBIT 4: Global Number of Telemedicine Patients (In Million) for the Years 2016, 2018, 2020, 2023 & 2025
    • COVID-19 Outbreak Accelerates Broader Use of Telemedicine
    • EXHIBIT 5: Telemedicine Leads Digital Health Investments Driven by Covid-19: Leading Categories of Digital Health by Funding (In US$ Million) for the Year 2020
    • EXHIBIT 6: Telehealth Visits in the U.S (In Million) for the Year 2020
    • COVID-19 Drives Prominence of Healthcare Analytics
    • Importance of Sharing Healthcare Data Picks up Momentum in the Covid-19 Era
    • The Move to Cloud Gains Momentum
    • Cloud-based EHR Systems
    • Rise in Funding to Drive Market Expansion
    • Increasing Usage of Smart Devices Bodes Well for Market Growth
    • EXHIBIT 7: Smartphone Penetration Rate as Share of Total Population: 2016-2021
    • Growing Deployment of Smart Devices Across Healthcare Augments the Need for Data Interoperability
    • IoMT: The New Healthcare 'Tech' Evolution - A Key Market Driver
    • EXHIBIT 8: Global IoT Market (In US$ Billion) by Industry for the Years 2018 and 2022
    • EXHIBIT 9: Number of Connected Medical Devices in Million: 2018-2025
    • Healthcare IT Market Enjoys Striking Leap Forward with Increasing Influx of IoT
    • Big Data Analytics Playing a Pivotal Role in Healthcare
    • EXHIBIT 10: Global Healthcare Data Generated: 2014, 2020, and 2025 (in exabytes)
    • Rising Need to Reduce Healthcare Costs to Propel Demand for Healthcare Interoperability Solutions
    • Use of EHRs and HIEs to Cut Down Healthcare Costs
    • Pressing Need to Curb Healthcare Costs Drive Interoperability Solutions Demand
    • EXHIBIT 11: Current & Required Healthcare Spending as % of GDP
    • EXHIBIT 12: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Rapidly Aging World Population & COVID-19 Induced Re-Focus on Aging-In-Place to Drive Demand
    • EXHIBIT 13: Aging Population Steps-Up The Burden on Healthcare: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Interoperability Challenges and Solutions
    • The Route to Improving Healthcare Interoperability
    • Transitioning to Advanced Data Infrastructures
    • Enforcing New Industry Standards
    • Supporting and Updating Systems
    • Regulations for Interoperability Standards Drive Market Growth
    • Information Blocking Final Rule
    • Interoperability and Patient Access Final Rule (CMS-9115-F)
    • Interoperability and Prior Authorization Final Rule (CMS-9123-F)
    • US Updates Regulatory Regime with New Rules
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Healthcare Interoperability Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Healthcare Interoperability Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Healthcare Interoperability Solutions by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
    • TABLE 4: World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 7: World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 10: World Current & Future Analysis for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Diagnosis by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 13: World Current & Future Analysis for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Treatment by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 16: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 19: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 22: World Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 25: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 28: USA Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 31: USA Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 34: USA Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: USA 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • CANADA
    • TABLE 37: Canada Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: Canada 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 40: Canada Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Canada Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Canada 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 43: Canada Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Canada Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Canada 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • JAPAN
    • TABLE 46: Japan Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Japan Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Japan 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 49: Japan Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Japan Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Japan 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 52: Japan Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Japan Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Japan 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • CHINA
    • TABLE 55: China Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: China Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: China 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 58: China Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: China Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: China 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 61: China Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: China Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: China 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • EUROPE
    • TABLE 64: Europe Current & Future Analysis for Healthcare Interoperability Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 65: Europe Historic Review for Healthcare Interoperability Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Europe 15-Year Perspective for Healthcare Interoperability Solutions by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
    • TABLE 67: Europe Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Europe Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Europe 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 70: Europe Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Europe Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Europe 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 73: Europe Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Europe Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Europe 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • FRANCE
    • TABLE 76: France Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: France Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: France 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 79: France Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: France Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: France 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 82: France Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: France Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: France 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • GERMANY
    • TABLE 85: Germany Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Germany Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Germany 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 88: Germany Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Germany Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Germany 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 91: Germany Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Germany Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Germany 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • ITALY
    • TABLE 94: Italy Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Italy Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Italy 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 97: Italy Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Italy Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Italy 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 100: Italy Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Italy Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Italy 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • UNITED KINGDOM
    • TABLE 103: UK Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: UK Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: UK 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 106: UK Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: UK Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: UK 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 109: UK Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: UK Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: UK 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • SPAIN
    • TABLE 112: Spain Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Spain Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: Spain 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 115: Spain Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Spain Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: Spain 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 118: Spain Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Spain Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Spain 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • RUSSIA
    • TABLE 121: Russia Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Russia Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Russia 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 124: Russia Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Russia Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Russia 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 127: Russia Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Russia Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Russia 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF EUROPE
    • TABLE 130: Rest of Europe Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of Europe Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Rest of Europe 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 133: Rest of Europe Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Europe Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of Europe 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 136: Rest of Europe Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of Europe Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Rest of Europe 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • ASIA-PACIFIC
    • TABLE 139: Asia-Pacific Current & Future Analysis for Healthcare Interoperability Solutions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 140: Asia-Pacific Historic Review for Healthcare Interoperability Solutions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Asia-Pacific 15-Year Perspective for Healthcare Interoperability Solutions by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
    • TABLE 142: Asia-Pacific Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Asia-Pacific Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Asia-Pacific 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 145: Asia-Pacific Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Asia-Pacific Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Asia-Pacific 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 148: Asia-Pacific Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Asia-Pacific Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Asia-Pacific 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • AUSTRALIA
    • TABLE 151: Australia Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Australia Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Australia 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 154: Australia Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Australia Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Australia 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 157: Australia Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Australia Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Australia 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • INDIA
    • TABLE 160: India Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: India Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: India 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 163: India Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: India Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: India 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 166: India Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: India Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: India 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • SOUTH KOREA
    • TABLE 169: South Korea Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: South Korea Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: South Korea 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 172: South Korea Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: South Korea Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: South Korea 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 175: South Korea Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: South Korea Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: South Korea 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 178: Rest of Asia-Pacific Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Rest of Asia-Pacific Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: Rest of Asia-Pacific 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 181: Rest of Asia-Pacific Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Rest of Asia-Pacific Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: Rest of Asia-Pacific 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 184: Rest of Asia-Pacific Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Rest of Asia-Pacific Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Rest of Asia-Pacific 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • LATIN AMERICA
    • TABLE 187: Latin America Current & Future Analysis for Healthcare Interoperability Solutions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 188: Latin America Historic Review for Healthcare Interoperability Solutions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Latin America 15-Year Perspective for Healthcare Interoperability Solutions by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
    • TABLE 190: Latin America Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Latin America Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Latin America 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 193: Latin America Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Latin America Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: Latin America 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 196: Latin America Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Latin America Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: Latin America 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • ARGENTINA
    • TABLE 199: Argentina Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Argentina Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: Argentina 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 202: Argentina Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Argentina Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Argentina 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 205: Argentina Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Argentina Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Argentina 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • BRAZIL
    • TABLE 208: Brazil Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Brazil Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Brazil 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 211: Brazil Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Brazil Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 213: Brazil 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 214: Brazil Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 215: Brazil Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 216: Brazil 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • MEXICO
    • TABLE 217: Mexico Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 218: Mexico Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 219: Mexico 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 220: Mexico Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 221: Mexico Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 222: Mexico 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 223: Mexico Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 224: Mexico Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 225: Mexico 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF LATIN AMERICA
    • TABLE 226: Rest of Latin America Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 227: Rest of Latin America Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 228: Rest of Latin America 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 229: Rest of Latin America Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 230: Rest of Latin America Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 231: Rest of Latin America 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 232: Rest of Latin America Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 233: Rest of Latin America Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 234: Rest of Latin America 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • MIDDLE EAST
    • TABLE 235: Middle East Current & Future Analysis for Healthcare Interoperability Solutions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 236: Middle East Historic Review for Healthcare Interoperability Solutions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 237: Middle East 15-Year Perspective for Healthcare Interoperability Solutions by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
    • TABLE 238: Middle East Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 239: Middle East Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 240: Middle East 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 241: Middle East Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 242: Middle East Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 243: Middle East 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 244: Middle East Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 245: Middle East Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 246: Middle East 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • IRAN
    • TABLE 247: Iran Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 248: Iran Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 249: Iran 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 250: Iran Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 251: Iran Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 252: Iran 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 253: Iran Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 254: Iran Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 255: Iran 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • ISRAEL
    • TABLE 256: Israel Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 257: Israel Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 258: Israel 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 259: Israel Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 260: Israel Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 261: Israel 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 262: Israel Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 263: Israel Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 264: Israel 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • SAUDI ARABIA
    • TABLE 265: Saudi Arabia Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 266: Saudi Arabia Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 267: Saudi Arabia 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 268: Saudi Arabia Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 269: Saudi Arabia Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 270: Saudi Arabia 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 271: Saudi Arabia Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 272: Saudi Arabia Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 273: Saudi Arabia 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 274: UAE Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 275: UAE Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 276: UAE 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 277: UAE Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 278: UAE Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 279: UAE 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 280: UAE Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 281: UAE Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 282: UAE 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF MIDDLE EAST
    • TABLE 283: Rest of Middle East Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 284: Rest of Middle East Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 285: Rest of Middle East 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 286: Rest of Middle East Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 287: Rest of Middle East Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 288: Rest of Middle East 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 289: Rest of Middle East Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 290: Rest of Middle East Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 291: Rest of Middle East 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027
  • AFRICA
    • TABLE 292: Africa Current & Future Analysis for Healthcare Interoperability Solutions by Type - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 293: Africa Historic Review for Healthcare Interoperability Solutions by Type - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 294: Africa 15-Year Perspective for Healthcare Interoperability Solutions by Type - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
    • TABLE 295: Africa Current & Future Analysis for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 296: Africa Historic Review for Healthcare Interoperability Solutions by Application - Diagnosis, Treatment and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 297: Africa 15-Year Perspective for Healthcare Interoperability Solutions by Application - Percentage Breakdown of Value Revenues for Diagnosis, Treatment and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 298: Africa Current & Future Analysis for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 299: Africa Historic Review for Healthcare Interoperability Solutions by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 300: Africa 15-Year Perspective for Healthcare Interoperability Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2021 & 2027

IV. COMPETITION

  • Total Companies Profiled: 68